Evidence map›Paper›PMID 36987100›Full record

ArticlePlants (Basel, Switzerland)2023

Green Biogenic of Silver Nanoparticles Using Polyphenolic Extract of Olive Leaf Wastes with Focus on Their Anticancer and Antimicrobial Activities.

Bassam F Alowaiesh, Haifa Abdulaziz Sakit Alhaithloul, Ahmed M Saad, Abdallah A Hassanin

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Silver Nanoparticles fromACS omega · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Green Synthesis and Characterization of Silver Nanoparticles UsingInternational journal of nanomedicine · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Potential Therapeutic Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Bassam F AlowaieshOlive Research Center, Jouf University, Sakaka 72341, Saudi Arabia.
Haifa Abdulaziz Sakit AlhaithloulOlive Research Center, Jouf University, Sakaka 72341, Saudi Arabia.
Ahmed M SaadBiochemistry Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.
Abdallah A HassaninGenetics Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.ORCID 0000-0002-1607-5539
Jouf University · SAZagazig University · EG

Funding

Al Jouf University DSR2022-RG-0164
6 · The paper itself

Abstract

Agro-industrial wastes are rich in polyphenols and other bioactive compounds, and valorizing these wastes is a crucial worldwide concern for saving health and the environment. In this work, olive leaf waste was valorized by silver nitrate to produce silver nanoparticles (OLAgNPs), which exhibited various biological, antioxidant, anticancer activities against three cancer cell lines, and antimicrobial activity against multi-drug resistant (MDR) bacteria and fungi. The obtained OLAgNPs were spherical, with an average size of 28 nm, negatively charged at -21 mV, and surrounded by various active groups more than the parent extract based on FTIR spectra. The total phenolic and total flavonoid contents significantly increased in OLAgNPs by 42 and 50% over the olive leaf waste extract (OLWE); consequently, the antioxidant activity of OLAgNPs increased by 12% over OLWE, recording an SC

Indexed as

cancerextractionMDR microorganismsmedical applicationsnanoparticlesolive leaveswastes

Identifiers

PMID36987100
PMCPMC10057938
OpenAlexW4353109818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.